Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A-101 for common warts
NCT03278028Phase 2Completed
- Sponsor
- Aclaris Therapeutics, Inc.
- Start
- Jul 2017
- Primary completion
- Mar 2018
- Countries
- 1
01
Overview
A Phase 2 trial of hydrogen peroxide in common wart, sponsored by Aclaris Therapeutics, Inc.. Started Jul 2017; status: completed.
02
Drugs
hydrogen peroxide
03
Conditions
common wart
Beyond the preview
Go deeper on NCT03278028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03278028.